Valeant Pharmaceuticals International Inc. received a joint takeover approach this spring from Japan’s Takeda Pharmaceutical Co. and private-equity firm TPG that the beleaguered drug maker rejected, according to people familiar with the matter.
WSJ.com: What's News Asia, Wall Street Journal: What's News Asia
Thu, 05/26/2016 - 4:37pm
Valeant Pharmaceuticals International Inc. received a joint takeover approach this spring from Japan’s Takeda Pharmaceutical Co. and private-equity firm TPG that the beleaguered drug maker rejected, according to people familiar with the matter.